Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP

This study has been completed.
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Mahidol University
ClinicalTrials.gov Identifier:
NCT00440583
First received: February 26, 2007
Last updated: January 28, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)